Cannabis use disorder linked to ~60% higher risk of adverse cardiovascular events, Canadian study finds

A recent study published in Addiction evaluated the associations of cannabis use disorder (CUD) with cardiovascular disease (CVD) outcomes.

Nitronazine by Guangzhou Magpie Pharmaceutical for Amyotrophic Lateral Sclerosis: Likelihood of Approval

Nitronazine is under clinical development by Guangzhou Magpie Pharmaceutical and currently in Phase II for Amyotrophic Lateral Sclerosis.

June 20, 2024

Study could explain why astronauts’ T cells become less effective at fighting infection

A new study led by researchers at Karolinska Institutet in Sweden has examined how T cells of the immune system are affected by weightlessness.

August 26, 2023

Wellbeing in the USA shows significant disparities, driven by race, sex, age, and location

A study reveals significant disparities in wellbeing across the U.S., influenced by race, ethnicity, and geography, affecting education, income, and lifespan.

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.